Crinetics Pharmaceuticals Inc (CRNX)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -95.547 | -64.95 | -28.998 | -33.415 | -47.041 | -40.28 | -46.621 | -43.448 |
| Return on Equity (%) | 194.036 | 86.281 | -37.348 | -36.358 | -51.606 | -42.982 | -50.571 | -50.157 |
| Return on Invested Capital (%) | 199.802 | 86.487 | -39.69 | -38.969 | -52.61 | -43.189 | -52.395 | -53.623 |
| Operating Margin (%) | -1020.034 | -447.384 | -1116.763 | -4226.488 | -103960.563 | -9985.25 | -3460.376 | -5345.851 |
| Net Profit Margin (%) | -1021.902 | -447.775 | -1116.763 | -4226.488 | -103960.563 | -9985.25 | -3460.376 | -5345.851 |
| Book Value Per Share | -0.174 | -0.254 | 1.326 | 0.968 | 1.301 | 3.458 | 3.093 | 4.68 |
| Earnings Per Share | -0.169 | -0.155 | -0.224 | -0.416 | -0.569 | -1.121 | -1.603 | -1.862 |
| Cash Per Share | 0.341 | 0.24 | 0.372 | 0.333 | 0.717 | 2.091 | 0.319 | 0.477 |
| Working Capital Per Share | 0.322 | 0.242 | 1.313 | 0.95 | 1.287 | 3.424 | 3.104 | 4.602 |
| Operating Profit Per Share | 0.017 | 0.035 | 0.02 | 0.01 | 0.001 | 0.011 | 0.046 | 0.035 |
| EBIT Per Share | -0.169 | -0.155 | -0.224 | -0.416 | -0.569 | -1.121 | -1.603 | -1.862 |
| EBITDA Per Share | -0.169 | -0.155 | -0.224 | -0.416 | -0.569 | -1.121 | -1.603 | -1.862 |
| Free Cash Flow Per Share | -0.166 | -0.152 | -0.219 | -0.42 | -0.574 | -1.126 | -1.596 | -1.831 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 1.17M | 1.55M | 24.06M | 24.26M | 33M | 47.6M | 53.88M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 53.88M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -1716.872 | N/A | N/A | N/A | -10384.375 | N/A | N/A |
| Net Profit Margin (%) | N/A | -1716.872 | N/A | N/A | N/A | -10457.813 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 3.29B |
| Price to Earnings Ratio | -15.83 |
| Price to Sales Ratio | 845.5 |
| Price to Cash Ratio | 61.84 |
| Price to Book Ratio | 6.3 |
| Dividend Yield | - |
| Shares Outstanding | 92.74M |
| Average Volume (1 week) | 691.54k |
| Average Volume (1 Month) | 804.81k |
| 52 Week Change | -3.11% |
| 52 Week High | 62.53 |
| 52 Week Low | 34.10 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
